BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 29189310)

  • 1. Muscle Damage Due to Fusidic Acid-Statin Interaction: Review of 75 Cases From the French Pharmacovigilance Database and Literature Reports.
    Bataillard M; Beyens MN; Mounier G; Vergnon-Miszczycha D; Bagheri H; Cathebras P
    Am J Ther; 2019; 26(3):e375-e379. PubMed ID: 29189310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Rhabdomyolysis following the coprescription of atorvastatin and fusidic acid].
    Gabignon C; Zeller V; Le Guyader N; Desplaces N; Lidove O; Ziza JM
    Rev Med Interne; 2013 Jan; 34(1):39-41. PubMed ID: 23102978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rhabdomyolysis after co-administration of a statin and fusidic acid: an analysis of the literature and of the WHO database of adverse drug reactions.
    Deljehier T; Pariente A; Miremont-Salamé G; Haramburu F; Nguyen L; Rubin S; Rigothier C; Théophile H
    Br J Clin Pharmacol; 2018 May; 84(5):1057-1063. PubMed ID: 29337401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presumed interaction of fusidic acid with simvastatin.
    Burtenshaw AJ; Sellors G; Downing R
    Anaesthesia; 2008 Jun; 63(6):656-8. PubMed ID: 18477279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe rhabdomyolysis as a consequence of the interaction of fusidic acid and atorvastatin.
    Magee CN; Medani SA; Leavey SF; Conlon PJ; Clarkson MR
    Am J Kidney Dis; 2010 Nov; 56(5):e11-5. PubMed ID: 20888103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rhabdomyolysis with atorvastatin and fusidic acid.
    O'Mahony C; Campbell VL; Al-Khayatt MS; Brull DJ
    Postgrad Med J; 2008 Jun; 84(992):325-7. PubMed ID: 18644925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe statin-induced rhabdomyolysis mimicking Guillain-Barré syndrome in four patients with diabetes mellitus treated with fusidic acid.
    Collidge TA; Razvi S; Nolan C; Whittle M; Stirling C; Russell AJ; Mann AC; Deighan CJ
    Diabet Med; 2010 Jun; 27(6):696-700. PubMed ID: 20546290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating the extent of reporting to FDA: a case study of statin-associated rhabdomyolysis.
    McAdams M; Staffa J; Dal Pan G
    Pharmacoepidemiol Drug Saf; 2008 Mar; 17(3):229-39. PubMed ID: 18175291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rhabdomyolysis and statins: A pharmacovigilance comparative study between statins.
    Montastruc JL
    Br J Clin Pharmacol; 2023 Aug; 89(8):2636-2638. PubMed ID: 37186323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rhabdomyolysis with HMG-CoA reductase inhibitors and gemfibrozil combination therapy.
    Chang JT; Staffa JA; Parks M; Green L
    Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):417-26. PubMed ID: 15269925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rhabdomyolysis following co-prescription of fusidic acid and atorvastatin.
    Teckchandani S; Robertson S; Almond A; Donaldson K; Isles C
    J R Coll Physicians Edinb; 2010 Mar; 40(1):33-6. PubMed ID: 21125037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statin Associated Muscular Adverse Effects.
    Kammoun R; Charfi O; Lakhoua G; Zaiem A; Daghfous R; Kastalli S; Aouinti I; Aidli SE
    Curr Drug Saf; 2024; 19(1):114-116. PubMed ID: 36847228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statins and erectile dysfunction: results of a case/non-case study using the French Pharmacovigilance System Database.
    Do C; Huyghe E; Lapeyre-Mestre M; Montastruc JL; Bagheri H
    Drug Saf; 2009; 32(7):591-7. PubMed ID: 19530745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statins for primary prevention and rhabdomyolysis: A nationwide cohort study in France.
    Coste J; Billionnet C; Rudnichi A; Pouchot J; Dray-Spira R; Giral P; Zureik M
    Eur J Prev Cardiol; 2019 Mar; 26(5):512-521. PubMed ID: 29799296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A timely reminder about the concomitant use of fusidic acid with statins.
    Cowan R; Johnson PD; Urbancic K; Grayson ML
    Clin Infect Dis; 2013 Jul; 57(2):329-30. PubMed ID: 23588554
    [No Abstract]   [Full Text] [Related]  

  • 16. Statin-associated myopathy.
    Thompson PD; Clarkson P; Karas RH
    JAMA; 2003 Apr; 289(13):1681-90. PubMed ID: 12672737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Statin-Associated Myopathy Case Reports in Thailand Using the Health Product Vigilance Center Database.
    Boonmuang P; Nathisuwan S; Chaiyakunapruk N; Suwankesawong W; Pokhagul P; Teerawattanapong N; Supsongserm P
    Drug Saf; 2013 Sep; 36(9):779-87. PubMed ID: 23615756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatal rhabdomyolysis following the co-prescription of fusidic acid and pravastatin.
    Bachoumas K; Fiancette M; Lascarrou JB; Lacherade JC; Leclair F; Reignier J
    Med Mal Infect; 2015 Oct; 45(10):417-9. PubMed ID: 26472060
    [No Abstract]   [Full Text] [Related]  

  • 19. Acute rhabdomyolysis after atorvastatin and fusidic acid therapy.
    Wenisch C; Krause R; Fladerer P; El Menjawi I; Pohanka E
    Am J Med; 2000 Jul; 109(1):78. PubMed ID: 10991749
    [No Abstract]   [Full Text] [Related]  

  • 20. Rhabdomyolysis a result of azithromycin and statins: an unrecognized interaction.
    Strandell J; Bate A; Hägg S; Edwards IR
    Br J Clin Pharmacol; 2009 Sep; 68(3):427-34. PubMed ID: 19740401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.